Developed & Manufactured by Biomedica
- Products
- By research area
- Bone Metabolism
- Cardiovascular
- Cell proliferation
- immunology
- Infectious disease
- Metabolic Disease
- Nephrology & Transplant
- Neurology
- Oncology
- Oxidative stress
- Toxicity
By product typeDeals of the month
Download biomedica product list
- Services
- ServicesDeals of the monthDownload biomedica product list
- Quality
- News
- About us
- Contact Us
- Downloads
Our ELISAs:
designed for your clinical
& preclinical application developed & manufactured
byFeatured Products & Promotions
FREE soluble RANKL HS ELISAHigh sensitivity – measurable concentrations in healthy subjectsLearn MoreOsteoprotegerin ELISADay testLearn MoreFGF23 (intact) human ELISACE-marked – for IVD use in the EULearn MoreLatest News-
Biomedica offers the FIRST fully validated VANIN-1 (urine) ELISA1 October, 2019Vanin-1 is a glycoprotein that is selectively expressed in renal tubular cells. Urinary Vanin-1 has as superior predictive value for drug induced AKI than KIM-1 or NGAL is a novel biomarker to detect and monitor the clinical course of obstructive nephropathy Related Literature & Findings: Urinary Vanin-1 As a Novel Biomarker for Early Detection of [...]
-
CE-mark for FGF23 (intact) human ELISA18 September, 2019Biomedica is proud to announce the launch of its CE-marked FGF23 (intact) human ELISA, cat# BI-20700 Features and Benefits RELIABLE & FULLY VALIDATED for plasma samples - according to ICH Q2 SERUM, URINE and CC SUPERNATANT are compatible with this ELISA FAST ONE-STEP ELISA - only 3.5 h total incubation time PLASMA BASED STANDARDS and CONTROLS INCLUDED [...]
-
FGF23 (intact) human ELISA as a featured product on Biocompare22 July, 2019The new intact FGF23 ELISA was mentioned in the most recent Biocompare newsletter as a featured product. Check out the drug discovery and development newsletter to learn more. FGF23 (intact) human ELISA Features and Benefits • RELIABLE and FULLY VALIDATED for plasma samples – according to ICH Q2 • SERUM, URINE and CC SUPERNATANT are compatible with [...]
Events-
Biomedica @ ASMBR18 September, 2019Meet us at the ASBMR in Orlando at The Biomedica booth # 516 Our Posters: #SUN-103, #SUN-271, #MON-252 and #MON-331 Tje Bone Turnover Markers Working Group Room# W307B, Sept 20 at 7:30pm Diurnal Changes in Serum Levels of Bone-Related Circulating MicroRNAs. Oral presentation #1140, room# W314, Monday, Sept 23 from 2:15pm-2:30pm If you cannot make it to the ASBMR [...]
-
Biomedica @ ICCBH in Salzburg17 June, 2019Meet Biomedica Immunoassays at poster P95 “Detection of intact FGF23 using a novel well-characterized ELISA” to learn more about new FGF23 (intact) human ELISA and to discuss your research projects! Useful links: Scientific Program FGF23 (intact) human ELISA
-
Biomedica @ ECTS Congress Budapest25 April, 2019May 11 – 14, 2019 Meet Biomedica Immunoassays at the ECTS Congress in Budapest - booth # 12 - to learn more about our soon to be launched new assay and to discuss your research projects!In addition to having a booth, we will present the following posters: Development and characterization of an extraction-free human CGRP [...]